These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10871819)

  • 1. Restaging with gallium scan identifies chemosensitive patients and predicts survival of poor-prognosis mediastinal Hodgkin's disease patients.
    Ionescu I; Brice P; Simon D; Guermazi A; Leblanc T; Rousselot P; Gossot D; Meignin V; Gisselbrecht C; Rain JD
    Med Oncol; 2000 May; 17(2):127-34. PubMed ID: 10871819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium-67 scans as an adjunct to computed tomography scans for the assessment of a residual mediastinal mass in pediatric patients with Hodgkin's disease. A Pediatric Oncology Group study.
    Weiner M; Leventhal B; Cantor A; Wimmer R; Berry DL; Cook B; Ducos R
    Cancer; 1991 Dec; 68(11):2478-80. PubMed ID: 1933785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
    King SC; Reiman RJ; Prosnitz LR
    J Clin Oncol; 1994 Feb; 12(2):306-11. PubMed ID: 8113837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
    Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
    Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
    Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
    Re A; Ferrari S; Frata P; Pizzocaro C; Crippa C; Tucci A; Facchetti F; Grazioli L; Magrini SM; Rossi G
    Ann Oncol; 2008 May; 19(5):951-7. PubMed ID: 18209012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.
    Ng AK; Bernardo MV; Silver B; Van Den Abbeele A; Stevenson MA; Fisher DC; Mauch PM
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):175-84. PubMed ID: 15629609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma.
    Gasparini MD; Balzarini L; Castellani MR; Tesoro Tess JD; Maffioli LS; Petrillo R; Ceglia E; Musumeci R; Buraggi GL
    Cancer; 1993 Jul; 72(2):577-82. PubMed ID: 8319190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beguiled by the gallium. Thymic rebound in an adult after chemotherapy for Hodgkin's disease.
    Burns DE; Schiffman FJ
    Chest; 1993 Dec; 104(6):1916-9. PubMed ID: 8252989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium scanning in the management of mediastinal Hodgkin's disease.
    Wylie BR; Southee AE; Joshua DE; McLaughlin AF; Gibson J; Hutton BF; Morris JG; Kronenberg H
    Eur J Haematol; 1989 Apr; 42(4):344-7. PubMed ID: 2721659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
    Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
    Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
    Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
    Blood; 1999 Jul; 94(2):429-33. PubMed ID: 10397709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy.
    Cooper DL; Caride VJ; Zloty M; Germino J; Farber LR; Hoffer PB
    J Clin Oncol; 1993 Jun; 11(6):1092-8. PubMed ID: 8501495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
    Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the gallium scan in Hodgkin's disease.
    Hagemeister FB; Fesus SM; Lamki LM; Haynie TP
    Cancer; 1990 Mar; 65(5):1090-6. PubMed ID: 2302660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
    Harris EW; Rakow JI; Weiner M; Agress H
    J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.
    Janicek M; Kaplan W; Neuberg D; Canellos GP; Shulman LN; Shipp MA
    J Clin Oncol; 1997 Apr; 15(4):1631-7. PubMed ID: 9193363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.